Latest

Medical innovations with big promise for 2015

Cleveland Clinic releases their annual list of highly promising innovations.

Withdraw FDA scientific pubs distribution guide: Public Citizen

Withdraw FDA scientific pubs distribution guide: Public Citizen

Public Citizen tells FDA it should withdraw draft guidance that it believes will allow drugmakers to tell physicians marketed drugs are less risky than their labels indicate.

Orphan drugs a niche no longer

Orphan drugs a niche no longer

Orphan drug growth will easily outpace non-orphans through 2020.

Programmatic buying stands to disrupt healthcare marketing

Programmatic buying stands to disrupt healthcare marketing

Programmatic ad buying hasn't exactly taken over the industry, but its approach has precipitated a paradigm shift, media experts say.

Five things for pharma marketers to know: Thursday, October 30

Five things for pharma marketers to know: Thursday, October 30

Sanofi courts AstraZeneca CEO Soriot; Teva CEO optimistic on Copaxone patent ruling; AstraZeneca scores approval of diabetes combo drug.

Ireland's drugmakers resist price cuts

The country's drug ministry has identified drugs as an area for savings.

Google foresees a disease early warning system fostered by tiny particles

Google foresees a disease early warning system fostered by tiny particles

The company unveils a plan for deploying controllable nanoparticles into peoples' bodies for monitoring health conditions.

Forbes's Matthew Herper sounds off on Viehbacher firing

Herper writes that Sanofi—without Viehbacher—is at risk of moving too slowly in an increasingly competitive industry.

India bans plastic packaging for drug liquids

Widely used plastics such as PET will have to be replaced with more costly glass containers.

Make all Rx contraceptives OTC, lawyer urges FDA

Make all Rx contraceptives OTC, lawyer urges FDA

The former FDA director of medical device compliance has petitioned the agency to make oral contraceptives over-the-counter.

Agency Spotlight


Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.